Product information

Current status:

Approved

Current status date:

2020-12-21

Product name:

LIDOCAINE

DIN:

02510057 Electronic product monograph is not available

Company:

PHARMA STULLN INC.
6500 Trans Canada Highway, Suite 400
Pointe-Claire
Quebec
Canada H9R 0A5

Class:

Human

Dosage form(s):

Gel

Route(s) of administration:

Topical

Number of active ingredient(s):

1

Schedule(s):

OTC

American Hospital Formulary Service (AHFS): ^{See footnote 3}

84:08.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

D04AB01 LIDOCAINE

Active ingredient group (AIG) number:^{See footnote5}

0101280001